Accessibility Menu
Stereotaxis Stock Quote

Stereotaxis (NYSEMKT: STXS)

$2.24
(-7.8%)
-0.19
Price as of November 13, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$2.24
Daily Change
(-7.8%) $0.19
Day's Range
$2.23 - $2.39
Previous Close
$2.24
Open
$2.37
Beta
1.19
Volume
1,183,367
Average Volume
535,684
Market Cap
221.3M
Market Cap / Employee
$2.43M
52wk Range
$1.54 - $3.59
Revenue
-
Gross Margin
0.57%
Dividend Yield
N/A
EPS
-$0.28
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Stereotaxis Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
STXS+1.82%-43.72%-10.85%-97%
S&P+14.49%+91.09%+13.83%+544%

Stereotaxis Company Info

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$7.46M-18.8%
Gross Profit$4.10M0.0%
Gross Margin54.94%10.4%
Market Cap$283.23M64.0%
Market Cap / Employee$2.04M0.0%
Employees13913.9%
Net Income-$6.46M-4.4%
EBITDA-$4.82M19.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$10.51M-4.6%
Accounts Receivable$5.33M-32.7%
Inventory10.112.6%

Liabilities

Q3 2025YOY Change
Long Term Debt$4.96M-11.2%
Short Term Debt$0.62M12.9%

Ratios

Q3 2025YOY Change
Return On Assets-48.96%-3.8%
Return On Invested Capital-61.60%-25.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$4.20M3.1%
Operating Free Cash Flow-$4.20M2.9%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book17.8624.7063.28183.701132.22%
Price to Sales7.355.625.869.5236.65%
Price to Tangible Book Value-104.91-29.78-22.71-29.05-294.87%
Enterprise Value to EBITDA-27.11-27.87-53.28-59.48103.72%
Return on Equity-144.2%-179.8%-198.6%-170.2%59.91%
Total Debt$6.01M$5.87M$5.73M$5.58M-9.00%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.